190 related articles for article (PubMed ID: 26388113)
1. Exacerbation of psoriasis vulgaris during nivolumab for oral mucosal melanoma.
Kato Y; Otsuka A; Miyachi Y; Kabashima K
J Eur Acad Dermatol Venereol; 2016 Oct; 30(10):e89-e91. PubMed ID: 26388113
[No Abstract] [Full Text] [Related]
2. Occurrence of Psoriasiform Eruption During Nivolumab Therapy for Primary Oral Mucosal Melanoma.
Ohtsuka M; Miura T; Mori T; Ishikawa M; Yamamoto T
JAMA Dermatol; 2015 Jul; 151(7):797-9. PubMed ID: 25875052
[No Abstract] [Full Text] [Related]
3. Exacerbation of Psoriasis During Nivolumab Therapy for Metastatic Melanoma.
Matsumura N; Ohtsuka M; Kikuchi N; Yamamoto T
Acta Derm Venereol; 2016 Feb; 96(2):259-60. PubMed ID: 26270860
[No Abstract] [Full Text] [Related]
4. Synergistic effects of interferon-beta and nivolumab in oral mucosal melanoma.
Fusumae T; Kamiya K; Chiang B; Okada H; Nakano N; Maekawa T; Komine M; Murata S; Ohtsuki M
J Dermatol; 2018 Jan; 45(1):87-90. PubMed ID: 28944501
[TBL] [Abstract][Full Text] [Related]
5. Case of de novo psoriasis possibly triggered by nivolumab.
Murata S; Kaneko S; Harada Y; Aoi N; Morita E
J Dermatol; 2017 Jan; 44(1):99-100. PubMed ID: 27177467
[No Abstract] [Full Text] [Related]
6. Abscopal effect of radiation therapy after nivolumab monotherapy in a patient with oral mucosal melanoma: A case report.
Igarashi H; Fukuda M; Konno Y; Takano H
Oral Oncol; 2020 Sep; 108():104919. PubMed ID: 32713809
[TBL] [Abstract][Full Text] [Related]
7. ADAMTSL5 is upregulated in melanoma tissues in patients with idiopathic psoriasis vulgaris induced by nivolumab.
Nonomura Y; Otsuka A; Ohtsuka M; Yamamoto T; Dummer R; Kabashima K
J Eur Acad Dermatol Venereol; 2017 Feb; 31(2):e100-e101. PubMed ID: 27461248
[No Abstract] [Full Text] [Related]
8. Nivolumab: Immunotherapy in Malignant Melanoma.
Bayless H; Schneider S
Clin J Oncol Nurs; 2015 Aug; 19(4):430-2. PubMed ID: 26207707
[TBL] [Abstract][Full Text] [Related]
9. [Psoriasis and psoriatic arthritis induced by nivolumab (Opdivo
Schmutz JL
Ann Dermatol Venereol; 2016 Dec; 143(12):881-882. PubMed ID: 27692689
[No Abstract] [Full Text] [Related]
10. Exacerbation of psoriasis induced by interferon-alpha treatment for melanoma.
Tas F; Atsu N
Cutan Ocul Toxicol; 2016 Mar; 35(1):83-4. PubMed ID: 25799214
[TBL] [Abstract][Full Text] [Related]
11. Polymyalgia rheumatica in a melanoma patient due to nivolumab treatment.
Nakamagoe K; Moriyama T; Maruyama H; Yokosawa M; Hara T; Tanaka S; Fujimoto M; Tamaoka A
J Cancer Res Clin Oncol; 2017 Jul; 143(7):1357-1358. PubMed ID: 28516380
[No Abstract] [Full Text] [Related]
12. Nivolumab for Metastatic Melanoma.
Gupta AK; Daigle D
Skin Therapy Lett; 2016 Mar; 21(2):6-9. PubMed ID: 27223114
[TBL] [Abstract][Full Text] [Related]
13. Nivolumab-induced hypophysitis in a patient with advanced malignant melanoma.
Okano Y; Satoh T; Horiguchi K; Toyoda M; Osaki A; Matsumoto S; Tomaru T; Nakajima Y; Ishii S; Ozawa A; Shibusawa N; Shimada T; Higuchi T; Chikamatsu K; Yamada M
Endocr J; 2016 Oct; 63(10):905-912. PubMed ID: 27440480
[TBL] [Abstract][Full Text] [Related]
14. Nivolumab and pembrolizumab as immune-modulating monoclonal antibodies targeting the PD-1 receptor to treat melanoma.
Faghfuri E; Faramarzi MA; Nikfar S; Abdollahi M
Expert Rev Anticancer Ther; 2015; 15(9):981-93. PubMed ID: 26313415
[TBL] [Abstract][Full Text] [Related]
15. Subacute CNS Demyelination after Treatment with Nivolumab for Melanoma.
Maurice C; Schneider R; Kiehl TR; Bavi P; Roehrl MH; Mason WP; Hogg D
Cancer Immunol Res; 2015 Dec; 3(12):1299-302. PubMed ID: 26419960
[TBL] [Abstract][Full Text] [Related]
16. Severe pneumonitis after nivolumab treatment in a patient with melanoma.
Watanabe S; Kimura H; Takato H; Waseda Y; Hara J; Sone T; Abo M; Maeda S; Matsushita T; Kasahara K
Allergol Int; 2016 Oct; 65(4):487-489. PubMed ID: 27184827
[No Abstract] [Full Text] [Related]
17. Nivolumab provides favorable results in patients with advanced melanoma.
Dangi-Garimella S
Am J Manag Care; 2014 Mar; 20(5 Spec No.):E11. PubMed ID: 25618626
[No Abstract] [Full Text] [Related]
18. Hypothyroidism associated with nivolumab treatment of unresectable malignant melanoma.
Imafuku K; Yoshino K; Yamaguchi K; Tsuboi S; Ohara K; Hata H
Clin Exp Dermatol; 2017 Mar; 42(2):217-218. PubMed ID: 28052364
[No Abstract] [Full Text] [Related]
19. The appearance of pustular psoriasis during antitumor necrosis factor therapy.
Goncalves DP; Laurindo I; Scheinberg MA
J Clin Rheumatol; 2006 Oct; 12(5):262. PubMed ID: 17023816
[No Abstract] [Full Text] [Related]
20. Flexural or inverse psoriasis in a patient with hidradenitis suppurativa receiving treatment with infliximab.
Nuño-González A; Dehesa L; Ricotti C; Kerdel F
Actas Dermosifiliogr; 2012 Dec; 103(10):936-7. PubMed ID: 23149048
[No Abstract] [Full Text] [Related]
[Next] [New Search]
